Single topical ivermectin head lice treatment very effective

Single topical ivermectin head lice treatment very effective
A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

David M. Pariser, M.D., from the Eastern Virginia Medical School in Norfolk, and colleagues randomly assigned 765 patients with head lice (6 months of age or older) to a single application of 0.5 percent lotion or vehicle control without nit combing.

The researchers found that a significantly greater percentage of the ivermectin group was free of lice on day two (94.9 versus 31.3 percent), day eight (85.2 versus 20.8 percent), and day 15 (73.8 versus 17.6 percent). Both groups had similar frequency and severity of adverse events.

"In conclusion, ivermectin has a well-established safety profile, on the basis of extensive oral use, and a novel mode of action," Pariser and colleagues conclude. "Topical ivermectin showed high efficacy within 24 hours, with most treated patients remaining louse-free through the final assessment two weeks after a single treatment, without the need for nit combing."

The study was funded by Topaz Pharmaceuticals (now Sanofi Pasteur), which provided the study medication; two authors disclosed to Topaz Pharmaceuticals and .

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Head lice beginning to show permethrin resistance

Jun 05, 2012

(HealthDay) -- Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14 percent have been found to be resistant to permethrin, suggesting ...

Sequential oral, topical tacrolimus benefits dermatitis

Sep 20, 2012

(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the ...

Recommended for you

New technology that is revealing the science of chewing

20 hours ago

CSIRO's 3D mastication modelling, demonstrated for the first time in Melbourne today, is starting to provide researchers with new understanding of how to reduce salt, sugar and fat in food products, as well ...

After skin cancer, removable model replaces real ear

Apr 11, 2014

(HealthDay)—During his 10-year struggle with basal cell carcinoma, Henry Fiorentini emerged minus his right ear, and minus the hearing that goes with it. The good news: Today, the 56-year-old IT programmer ...

Italy scraps ban on donor-assisted reproduction

Apr 09, 2014

Italy's Constitutional Court on Wednesday struck down a Catholic Church-backed ban against assisted reproduction with sperm or egg donors that has forced thousands of sterile couples to seek help abroad.

Pot growers association launched in Jamaica

Apr 06, 2014

A group of influential Jamaicans gathered Saturday to launch an association of supposed future marijuana cultivators as momentum builds toward loosening laws prohibiting pot on the Caribbean island.

User comments